Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2025 Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2025 Earnings Call Transcript May 8, 2025

John Menditto – VP of IR and Corporate Communications:

David Mazzo – President and CEO:

James Nisco – SVP of Finance and Treasury and Chief Accounting Officer:

Kristen Buck – EVP of R&D and Chief Medical Officer:

Operator: Welcome to the Lisata Therapeutics First Quarter 2025 Financial Results and Business Update Conference Call. Currently, all participants are in listen-only mode. Following management’s...